GFM
MRNA icon

GF Fund Management’s Moderna MRNA Stock Holding History

GF Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446K Buy
8,775
+1,098
+14% +$51.2K 0.01% 226
2025
Q4 		$226K Sell
7,677
-694
-8% -$18.9K ﹤0.01% 284
2025
Q3 		$216K Sell
8,371
-1,482
-15% -$41.3K ﹤0.01% 283
2025
Q2 		$272K Sell
9,853
-533
-5% -$14K 0.01% 295
2025
Q1 		$294K Buy
10,386
+1,435
+16% +$50.9K 0.01% 290
2024
Q4 		$372K Buy
+8,951
New +$428K 0.01% 245

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GF Fund Management's MRNA Position: Q1 2026 in Review

GF Fund Management increased its Moderna (MRNA) stake by 14% in Q1 2026, buying an estimated $51.2K and bringing the position to 8,775 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #226.

GF Fund Management first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • GF Fund Management held 8,775 shares of Moderna worth $446K as of Q1 2026.
  • GF Fund Management bought 1,098 Moderna shares in Q1 2026, an estimated $51.2K.
  • Moderna made up 0.01% of GF Fund Management's portfolio in Q1 2026, its #226 holding.
  • GF Fund Management first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.